---
title: "Longshenrongfa Pharmaceutical Industry released its performance for the first three quarters, with a net profit attributable to the parent company of 27.0294 million yuan, an increase of 8.11%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262585963.md"
description: "Longshenrongfa Pharmaceutical Industry released its Q3 2025 report, with operating revenue for the first three quarters at 647 million yuan, a year-on-year decrease of 16.12%. The net profit attributable to the parent company was 27.0294 million yuan, a year-on-year increase of 8.11%. The net profit after deducting non-recurring gains and losses was 28.7134 million yuan, a year-on-year increase of 31.14%. The basic earnings per share were 0.0891 yuan"
datetime: "2025-10-24T09:34:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262585963.md)
  - [en](https://longbridge.com/en/news/262585963.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262585963.md)
generator: "portal-rs"
---

# Longshenrongfa Pharmaceutical Industry released its performance for the first three quarters, with a net profit attributable to the parent company of 27.0294 million yuan, an increase of 8.11%

According to the Zhitong Finance APP, Longshenrongfa Pharmaceutical Industry (300534.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 647 million yuan, a year-on-year decrease of 16.12%. The net profit attributable to shareholders of the listed company was 27.0294 million yuan, a year-on-year increase of 8.11%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 28.7134 million yuan, a year-on-year increase of 31.14%. The basic earnings per share were 0.0891 yuan

### Related Stocks

- [300534.CN](https://longbridge.com/en/quote/300534.CN.md)

## Related News & Research

- [North Sea Crude-WTI weakens on lower offer](https://longbridge.com/en/news/296813963.md)
- [Eden Research Reports Revenue Of £4.90 Million For 15 Months Ended 31 March 2026](https://longbridge.com/en/news/296994948.md)
- [Endovia Health opens FDA INAD file for CannEpil veterinary program](https://longbridge.com/en/news/296915045.md)
- [Eltel buys EWII street lighting business in Jutland](https://longbridge.com/en/news/297005499.md)
- [OHB-backed Rocket Factory Augsburg signs ESA contract under European Launcher Challenge](https://longbridge.com/en/news/297156222.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**